| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $161.9M | -2.4% |
| Gross Profit | $108.5M | -7.3% |
| R&D Expense | $12.1M | -6.7% |
| SG&A Expense | $52.5M | -0.1% |
| Operating Income | $1.2M | -41.9% |
| Pre-tax Income | -$34.4M | -882.2% |
| Income Tax | -$613K | -123.8% |
| Net Income | -$33.4M | -515.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.4M | -12.2% |
| Accounts Receivable | $58.4M | +9.1% |
| Inventory | $25.4M | +28.6% |
| Current Assets | $158.7M | +2.3% |
| Total Assets | $697.7M | -4.8% |
| Current Liabilities | $66.4M | +33.7% |
| Long-term Debt | $253.1M | -0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.2M | -68.9% |
| Capital Expenditures | $4.0M | +0.3% |
| Investing Cash Flow | -$4.0M | -0.3% |
| Financing Cash Flow | -$13.6M | +56.6% |
| Free Cash Flow | $12.1M | -74.7% |
| Total Liabilities |
| $354.5M |
| +2.8% |
| Stockholders' Equity | $174.0M | -24.5% |